Having been tortured by DXB for almost as long as I’ve been tortured by PAA, there is one enormous difference - DXB is receiving real
money from smallish pharma. I have to say, at one stage it looked unlikely that DXB would survive (I actually sold out of DXB completely last fin year at a loss. I got back in after an unlikely catalyst - they registered a god awful name for their primary product, a name never mentioned again, as it is unpronounceable. It was in the 6-7c range at the time).
Does PAA look better than DXB at that time? A million percent. Is PAA cursed or a smoke and mirror act? A possibility. Will they ever receive money for MPL? History is suggesting not, but we live in hope. Absolutely no guarantees, we all know that.
Ann: OLE Study update reveals impressive Survival Data, page-134
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 89494 | 4 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |